Prostamax
Also known as: KEDP, Lys-Glu-Asp-Pro, Prostate Bioregulator, Prostatic Peptide, Libidon
KEDP Tetrapeptide | Prostate Bioregulator
Overview
Prostamax is a Khavinson bioregulator tetrapeptide (KEDP) with primary repair effects on prostate tissue. Developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, it alters chromatin structure in cells from elderly individuals, promoting deheterochromatinization and potentially reactivating genes repressed during aging. Research in rat models shows reduced prostate inflammation, decreased swelling, and decelerated pathological remodeling associated with prostatitis.
Key benefits
- Reduces prostate inflammation
- Decreases prostatic swelling
- Reduces vascular congestion (hyperemia)
- Decreases immune cell infiltration
- Reduces scarring in prostate tissue
- Promotes chromatin decondensation
- Reactivates age-repressed genes
- Improves lymphocyte function
Mechanism of action
Prostamax works through epigenetic regulation by altering chromatin structure. It increases the frequency of sister chromatid exchanges and Ag-positive nucleolar organizer regions (NORs), while reducing large segments of pericentromeric heterochromatin. These changes promote chromatin decondensation and deheterochromatinization, potentially reactivating genes repressed during aging. The peptide influences heterochromatin arrangements in human lymphocytes and normalizes age-related changes in cellular function.
Molecular data
- Type
- Tetrapeptide bioregulator
- Half-life
- Not established
Sequence
Lys-Glu-Asp-Pro
Indications
What the research community uses this compound for, with self-reported effectiveness.
Prostate Health
Anti-Aging
Dosing protocols
Common protocols by delivery method. Adjust the curve below to model accumulation in your own cycle.
Delivery method
| Protocol | Dose | Frequency | Duration |
|---|---|---|---|
| — | 10-20 mg | Daily for 10-20 days | — |
| — | 10 mg | 2-3 cycles yearly | — |
Delivery method
| Protocol | Dose | Frequency | Duration |
|---|---|---|---|
| — | 10 mg | Daily for 10-15 days | — |
Safety
Reported adverse effects, contraindications, and what to monitor on cycle.
Common side effects
- Generally well-tolerated
- Minimal side effects reported
Rare side effects
- Allergic reactions (rare)
Contraindications
- Prostate cancer (consult oncologist)
- Known hypersensitivity
- Pregnancy (not applicable)
Monitoring
- PSA testing recommended for men over 50
- Urological evaluation if symptoms persist